GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Caprin-2 (C1q domain-containing protein 1) (Cytoplasmic activation/proliferation-associated protein 2) (Gastric cancer multidrug resistance-associated protein) (Protein EEG-1) (RNA granule protein 140)

 CAPR2_HUMAN             Reviewed;        1127 AA.
Q6IMN6; E4NKG2; Q149P6; Q149P7; Q6IMN5; Q7Z371; Q8TE70; Q8TE71;
Q96RN6; Q9H667; Q9HAL4;
11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
05-JUL-2004, sequence version 1.
13-FEB-2019, entry version 119.
RecName: Full=Caprin-2;
AltName: Full=C1q domain-containing protein 1;
AltName: Full=Cytoplasmic activation/proliferation-associated protein 2;
AltName: Full=Gastric cancer multidrug resistance-associated protein;
AltName: Full=Protein EEG-1;
AltName: Full=RNA granule protein 140;
Name=CAPRIN2 {ECO:0000312|EMBL:AAI17673.1};
Synonyms=C1QDC1, EEG1 {ECO:0000312|EMBL:AAL71549.1}, KIAA1873, RNG140;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1] {ECO:0000305, ECO:0000312|EMBL:AAL71549.1}
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 5), FUNCTION, SUBCELLULAR
LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
TISSUE=Erythroblast {ECO:0000312|EMBL:AAL71549.1};
PubMed=14593112; DOI=10.1074/jbc.M305634200;
Aerbajinai W., Lee Y.T., Wojda U., Barr V.A., Miller J.L.;
"Cloning and characterization of a gene expressed during terminal
differentiation that encodes a novel inhibitor of growth.";
J. Biol. Chem. 279:1916-1921(2004).
[2] {ECO:0000305}
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16541075; DOI=10.1038/nature04569;
Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
Kucherlapati R., Weinstock G., Gibbs R.A.;
"The finished DNA sequence of human chromosome 12.";
Nature 440:346-351(2006).
[3] {ECO:0000305, ECO:0000312|EMBL:AAI17673.1}
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 10), AND
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 844-1127 (ISOFORMS 1/2/4).
TISSUE=Brain {ECO:0000312|EMBL:AAH66295.1}, and Uterus;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4] {ECO:0000305, ECO:0000312|EMBL:BAB13830.1}
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 298-776 (ISOFORM 1),
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-776 (ISOFORM 4), AND
VARIANT VAL-519.
TISSUE=Embryo {ECO:0000312|EMBL:BAB13830.1}, and
Small intestine {ECO:0000312|EMBL:BAB15398.1};
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5] {ECO:0000305, ECO:0000312|EMBL:AAK83153.1}
NUCLEOTIDE SEQUENCE [MRNA] OF 319-1127 (ISOFORM 6).
Shi Y.-Q., Zhai H.-H., Han Y., Wang X., Wu H.-P., Fan D.-M.;
"Isolation and functional characterization of a novel gene associated
with gastric cancer multidrug resistance.";
Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 766-1127 (ISOFORM 7).
TISSUE=Cerebellum;
PubMed=17974005; DOI=10.1186/1471-2164-8-399;
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
"The full-ORF clone resource of the German cDNA consortium.";
BMC Genomics 8:399-399(2007).
[7] {ECO:0000305, ECO:0000312|EMBL:DAA01119.1}
IDENTIFICATION (ISOFORM 9).
PubMed=14764709; DOI=10.4049/jimmunol.172.4.2389;
Grill B., Wilson G.M., Zhang K.-X., Wang B., Doyonnas R., Quadroni M.,
Schrader J.W.;
"Activation/division of lymphocytes results in increased levels of
cytoplasmic activation/proliferation-associated protein-1: prototype
of a new family of proteins.";
J. Immunol. 172:2389-2400(2004).
[8]
FUNCTION, INTERACTION WITH LRP5 AND LRP6, AND IDENTIFICATION BY MASS
SPECTROMETRY.
PubMed=18762581; DOI=10.1083/jcb.200803147;
Ding Y., Xi Y., Chen T., Wang J.Y., Tao D.L., Wu Z.L., Li Y.P., Li C.,
Zeng R., Li L.;
"Caprin-2 enhances canonical Wnt signaling through regulating LRP5/6
phosphorylation.";
J. Cell Biol. 182:865-872(2008).
[9]
IDENTIFICATION.
PubMed=20516077; DOI=10.1074/jbc.M110.108944;
Shiina N., Tokunaga M.;
"RNA granule protein 140 (RNG140), a paralog of RNG105 localized to
distinct RNA granules in neuronal dendrites in the adult vertebrate
brain.";
J. Biol. Chem. 285:24260-24269(2010).
[10]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[11]
FUNCTION, IDENTIFICATION IN A COMPLEX WITH LRP6; CCNY AND CDK14, AND
SUBCELLULAR LOCATION.
PubMed=27821587; DOI=10.1074/jbc.M116.744607;
Wang X., Jia Y., Fei C., Song X., Li L.;
"Caprin-2 positively regulates CDK14/Cyclin Y-mediated LRP5/6
constitutive phosphorylation.";
J. Biol. Chem. 291:26427-26434(2016).
[12]
X-RAY CRYSTALLOGRAPHY (1.49 ANGSTROMS) OF 996-1127 IN COMPLEX WITH
CALCIUM, SUBUNIT, INTERACTION WITH LRP6, AND MUTAGENESIS OF ILE-1048;
ASP-1078; GLU-1084; ILE-1091; TRP-1114 AND TYR-1122.
PubMed=25331957; DOI=10.1074/jbc.M114.591636;
Miao H., Jia Y., Xie S., Wang X., Zhao J., Chu Y., Zhou Z., Shi Z.,
Song X., Li L.;
"Structural insights into the C1q domain of Caprin-2 in canonical Wnt
signaling.";
J. Biol. Chem. 289:34104-34113(2014).
-!- FUNCTION: Promotes phosphorylation of the Wnt coreceptor LRP6,
leading to increased activity of the canonical Wnt signaling
pathway (PubMed:18762581). Faciliates constitutive LRP6
phosphorylation by CDK14/CCNY during G2/M stage of the cell cycle,
which may potentiate cells for Wnt signaling (PubMed:27821587).
May regulate the transport and translation of mRNAs, modulating
for instance the expression of proteins involved in synaptic
plasticity in neurons (By similarity). Involved in regulation of
growth as erythroblasts shift from a highly proliferative state
towards their terminal phase of differentiation (PubMed:14593112).
May be involved in apoptosis (PubMed:14593112).
{ECO:0000250|UniProtKB:Q05A80, ECO:0000269|PubMed:14593112,
ECO:0000269|PubMed:18762581, ECO:0000269|PubMed:27821587}.
-!- SUBUNIT: Homotrimer; via C1q domain (PubMed:25331957). Found in a
complex with LRP6, CCNY and CDK14 during G2/M stage; CAPRIN2
functions as a scaffold for the complex by binding to CCNY via its
N terminus and to CDK14 via its C terminus (PubMed:27821587).
Interacts with LRP5 (PubMed:18762581). Interacts with LRP6
(PubMed:18762581, PubMed:25331957). {ECO:0000269|PubMed:18762581,
ECO:0000269|PubMed:25331957}.
-!- INTERACTION:
O75197:LRP5; NbExp=3; IntAct=EBI-6918449, EBI-2466421;
P50542:PEX5; NbExp=3; IntAct=EBI-6918449, EBI-597835;
-!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm.
-!- SUBCELLULAR LOCATION: Isoform 2: Mitochondrion. Cytoplasm.
Note=Expressed throughout the cytoplasm.
-!- SUBCELLULAR LOCATION: Isoform 5: Mitochondrion. Note=Colocalizes
with aggregated mitochondria.
-!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:27821587};
Peripheral membrane protein {ECO:0000305}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=9;
Name=1 {ECO:0000269|PubMed:16541075};
IsoId=Q6IMN6-1; Sequence=Displayed;
Note=No experimental confirmation available. {ECO:0000305};
Name=2 {ECO:0000269|PubMed:14593112}; Synonyms=EEG-1L
{ECO:0000269|PubMed:14593112};
IsoId=Q6IMN6-2; Sequence=VSP_052536, VSP_027920;
Name=3 {ECO:0000269|PubMed:15489334};
IsoId=Q6IMN6-3; Sequence=VSP_027920, VSP_052538, VSP_052539;
Note=No experimental confirmation available. {ECO:0000305};
Name=4 {ECO:0000269|PubMed:14702039};
IsoId=Q6IMN6-4; Sequence=VSP_052531;
Note=No experimental confirmation available. {ECO:0000305};
Name=5 {ECO:0000269|PubMed:14593112}; Synonyms=EEG-1S
{ECO:0000269|PubMed:14593112};
IsoId=Q6IMN6-5; Sequence=VSP_052532, VSP_052533;
Name=6 {ECO:0000269|Ref.5};
IsoId=Q6IMN6-6; Sequence=VSP_052534, VSP_052535;
Name=7;
IsoId=Q6IMN6-7; Sequence=VSP_052537, VSP_052538, VSP_052539;
Note=No experimental confirmation available. {ECO:0000305};
Name=9;
IsoId=Q6IMN6-9; Sequence=VSP_027920;
Note=No experimental confirmation available.;
Name=10;
IsoId=Q6IMN6-10; Sequence=VSP_043293, VSP_052537, VSP_052538,
VSP_052539;
Note=No experimental confirmation available. {ECO:0000305};
-!- TISSUE SPECIFICITY: Detected in all tissues tested with highest
levels of expression in brain and spleen.
{ECO:0000269|PubMed:14593112}.
-!- DEVELOPMENTAL STAGE: Expression is highly regulated during
erythroid development with increased expression at the stage of
differentiation associated with the onset of global nuclear
condensation and reduced cell proliferation.
{ECO:0000269|PubMed:14593112}.
-!- DOMAIN: The C1q domain is essential for the function in Wnt
signaling. {ECO:0000269|PubMed:18762581}.
-!- SIMILARITY: Belongs to the caprin family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=AAK83153.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AY074490; AAL71549.1; -; mRNA.
EMBL; AY074491; AAL71550.1; -; mRNA.
EMBL; AC010198; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC066295; AAH66295.1; -; mRNA.
EMBL; BC111007; AAI11008.1; -; mRNA.
EMBL; BC117672; AAI17673.1; -; mRNA.
EMBL; BC117673; AAI17674.1; -; mRNA.
EMBL; AK021453; BAB13830.1; -; mRNA.
EMBL; AK026222; BAB15398.1; -; mRNA.
EMBL; AF326778; AAK83153.1; ALT_INIT; mRNA.
EMBL; BX538080; CAD98004.1; -; mRNA.
EMBL; BK001102; DAA01119.1; -; mRNA.
EMBL; BK001103; DAA01120.1; -; mRNA.
EMBL; BR000870; FAA00695.1; -; mRNA.
CCDS; CCDS41766.2; -. [Q6IMN6-3]
CCDS; CCDS55816.1; -. [Q6IMN6-10]
CCDS; CCDS8720.1; -. [Q6IMN6-2]
RefSeq; NP_001002259.1; NM_001002259.2. [Q6IMN6-1]
RefSeq; NP_001193785.1; NM_001206856.2. [Q6IMN6-10]
RefSeq; NP_001306771.1; NM_001319842.1.
RefSeq; NP_001306772.1; NM_001319843.1. [Q6IMN6-9]
RefSeq; NP_076414.2; NM_023925.4. [Q6IMN6-2]
RefSeq; NP_115532.3; NM_032156.4. [Q6IMN6-3]
RefSeq; XP_006719210.1; XM_006719147.3. [Q6IMN6-7]
UniGene; Hs.234355; -.
PDB; 4OUL; X-ray; 1.95 A; A/B/C/D/E/F=996-1127.
PDB; 4OUM; X-ray; 1.49 A; A=996-1127.
PDB; 5J97; X-ray; 2.55 A; A/B=199-329.
PDBsum; 4OUL; -.
PDBsum; 4OUM; -.
PDBsum; 5J97; -.
ProteinModelPortal; Q6IMN6; -.
SMR; Q6IMN6; -.
BioGrid; 122431; 6.
IntAct; Q6IMN6; 5.
iPTMnet; Q6IMN6; -.
PhosphoSitePlus; Q6IMN6; -.
BioMuta; CAPRIN2; -.
DMDM; 74748798; -.
EPD; Q6IMN6; -.
jPOST; Q6IMN6; -.
MaxQB; Q6IMN6; -.
PeptideAtlas; Q6IMN6; -.
PRIDE; Q6IMN6; -.
ProteomicsDB; 66433; -.
ProteomicsDB; 66434; -. [Q6IMN6-10]
ProteomicsDB; 66435; -. [Q6IMN6-2]
ProteomicsDB; 66436; -. [Q6IMN6-3]
ProteomicsDB; 66437; -. [Q6IMN6-4]
ProteomicsDB; 66438; -. [Q6IMN6-5]
ProteomicsDB; 66439; -. [Q6IMN6-6]
ProteomicsDB; 66440; -. [Q6IMN6-7]
ProteomicsDB; 66441; -. [Q6IMN6-9]
Ensembl; ENST00000298892; ENSP00000298892; ENSG00000110888. [Q6IMN6-2]
Ensembl; ENST00000395805; ENSP00000379150; ENSG00000110888. [Q6IMN6-10]
Ensembl; ENST00000417045; ENSP00000391479; ENSG00000110888. [Q6IMN6-3]
Ensembl; ENST00000454014; ENSP00000403876; ENSG00000110888. [Q6IMN6-5]
GeneID; 65981; -.
KEGG; hsa:65981; -.
UCSC; uc001rjh.2; human. [Q6IMN6-1]
CTD; 65981; -.
DisGeNET; 65981; -.
EuPathDB; HostDB:ENSG00000110888.17; -.
GeneCards; CAPRIN2; -.
HGNC; HGNC:21259; CAPRIN2.
HPA; HPA039746; -.
MIM; 610375; gene.
neXtProt; NX_Q6IMN6; -.
OpenTargets; ENSG00000110888; -.
PharmGKB; PA162381044; -.
GeneTree; ENSGT00940000153438; -.
HOGENOM; HOG000082543; -.
HOVERGEN; HBG057777; -.
InParanoid; Q6IMN6; -.
KO; K18744; -.
OMA; PNLPKCW; -.
OrthoDB; 155962at2759; -.
PhylomeDB; Q6IMN6; -.
TreeFam; TF329471; -.
SignaLink; Q6IMN6; -.
SIGNOR; Q6IMN6; -.
ChiTaRS; CAPRIN2; human.
GeneWiki; CAPRIN2; -.
GenomeRNAi; 65981; -.
PRO; PR:Q6IMN6; -.
Proteomes; UP000005640; Chromosome 12.
Bgee; ENSG00000110888; Expressed in 222 organ(s), highest expression level in cerebellar vermis.
ExpressionAtlas; Q6IMN6; baseline and differential.
Genevisible; Q6IMN6; HS.
GO; GO:0005813; C:centrosome; IDA:HPA.
GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
GO; GO:0005829; C:cytosol; IDA:HPA.
GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
GO; GO:0005634; C:nucleus; IDA:HPA.
GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
GO; GO:0043235; C:receptor complex; IDA:BHF-UCL.
GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
GO; GO:0005102; F:signaling receptor binding; IPI:BHF-UCL.
GO; GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB.
GO; GO:0017148; P:negative regulation of translation; IEA:UniProtKB-KW.
GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:BHF-UCL.
GO; GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:UniProtKB.
GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:UniProtKB.
GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL.
GO; GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
Gene3D; 2.60.120.40; -; 1.
InterPro; IPR001073; C1q_dom.
InterPro; IPR028816; Caprin.
InterPro; IPR022070; Caprin-1_C.
InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
PANTHER; PTHR22922; PTHR22922; 1.
Pfam; PF00386; C1q; 1.
Pfam; PF12287; Caprin-1_C; 1.
PRINTS; PR00007; COMPLEMNTC1Q.
SMART; SM00110; C1Q; 1.
SUPFAM; SSF49842; SSF49842; 1.
PROSITE; PS50871; C1Q; 1.
1: Evidence at protein level;
3D-structure; Alternative splicing; Calcium; Cell membrane;
Coiled coil; Complete proteome; Cytoplasm; Differentiation;
Growth regulation; Membrane; Metal-binding; Mitochondrion;
Phosphoprotein; Polymorphism; Protein synthesis inhibitor;
Reference proteome; RNA-binding.
CHAIN 1 1127 Caprin-2.
/FTId=PRO_0000302082.
DOMAIN 993 1127 C1q. {ECO:0000255|PROSITE-
ProRule:PRU00368}.
COILED 129 156 {ECO:0000255}.
COILED 194 216 {ECO:0000255}.
METAL 1078 1078 Calcium 1; shared with neighboring
subunits. {ECO:0000244|PDB:4OUL,
ECO:0000269|PubMed:25331957}.
METAL 1084 1084 Calcium 2; shared with neighboring
subunits. {ECO:0000244|PDB:4OUL,
ECO:0000269|PubMed:25331957}.
MOD_RES 948 948 Phosphoserine.
{ECO:0000250|UniProtKB:Q05A80}.
MOD_RES 949 949 Phosphoserine.
{ECO:0000250|UniProtKB:Q05A80}.
VAR_SEQ 1 333 Missing (in isoform 4).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_052531.
VAR_SEQ 270 278 SVEDQMEQS -> RQTLEGSTV (in isoform 5).
{ECO:0000303|PubMed:14593112}.
/FTId=VSP_052532.
VAR_SEQ 279 1127 Missing (in isoform 5).
{ECO:0000303|PubMed:14593112}.
/FTId=VSP_052533.
VAR_SEQ 596 596 P -> S (in isoform 6).
{ECO:0000303|Ref.5}.
/FTId=VSP_052534.
VAR_SEQ 597 1127 Missing (in isoform 6).
{ECO:0000303|Ref.5}.
/FTId=VSP_052535.
VAR_SEQ 682 716 Missing (in isoform 10).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_043293.
VAR_SEQ 717 765 Missing (in isoform 2).
{ECO:0000303|PubMed:14593112}.
/FTId=VSP_052536.
VAR_SEQ 823 843 Missing (in isoform 7 and isoform 10).
{ECO:0000303|PubMed:15489334,
ECO:0000303|PubMed:17974005}.
/FTId=VSP_052537.
VAR_SEQ 823 823 Missing (in isoform 2, isoform 3 and
isoform 9). {ECO:0000303|PubMed:14593112,
ECO:0000303|PubMed:15489334}.
/FTId=VSP_027920.
VAR_SEQ 940 961 GWSDSSQVSSPERDNETFNSGD -> NCFIMRNSLLLIKQQ
GGVILLR (in isoform 3, isoform 7 and
isoform 10).
{ECO:0000303|PubMed:15489334,
ECO:0000303|PubMed:17974005}.
/FTId=VSP_052538.
VAR_SEQ 962 1127 Missing (in isoform 3, isoform 7 and
isoform 10).
{ECO:0000303|PubMed:15489334,
ECO:0000303|PubMed:17974005}.
/FTId=VSP_052539.
VARIANT 114 114 P -> S (in dbSNP:rs17688567).
/FTId=VAR_048445.
VARIANT 237 237 K -> R (in dbSNP:rs12146709).
/FTId=VAR_048446.
VARIANT 519 519 M -> V (in dbSNP:rs2304630).
{ECO:0000269|PubMed:14702039}.
/FTId=VAR_034939.
VARIANT 655 655 S -> L (in dbSNP:rs2304628).
/FTId=VAR_048447.
MUTAGEN 1048 1048 I->R: Impaired homotrimer formation. No
effect on LRP6 binding although LRP6
phosphorylation is significantly reduced.
{ECO:0000269|PubMed:25331957}.
MUTAGEN 1078 1078 D->A: Loss of calcium binding and
increased homotrimer stability; when
associated with Ala-1084.
{ECO:0000269|PubMed:25331957}.
MUTAGEN 1084 1084 E->A: Loss of calcium binding and
increased homotrimer stability; when
associated with Ala-1078.
{ECO:0000269|PubMed:25331957}.
MUTAGEN 1091 1091 I->S: Impaired homotrimer formation. No
effect on LRP6 binding although LRP6
phosphorylation is significantly reduced.
{ECO:0000269|PubMed:25331957}.
MUTAGEN 1114 1114 W->S: No effect on homotrimer formation.
{ECO:0000269|PubMed:25331957}.
MUTAGEN 1122 1122 Y->S: No effect on homotrimer formation.
{ECO:0000269|PubMed:25331957}.
CONFLICT 298 298 Y -> D (in Ref. 4; BAB13830).
{ECO:0000305}.
CONFLICT 320 320 P -> S (in Ref. 5; AAK83153).
{ECO:0000305}.
CONFLICT 595 595 V -> A (in Ref. 4; BAB13830).
{ECO:0000305}.
HELIX 199 227 {ECO:0000244|PDB:5J97}.
HELIX 230 237 {ECO:0000244|PDB:5J97}.
TURN 238 241 {ECO:0000244|PDB:5J97}.
HELIX 248 261 {ECO:0000244|PDB:5J97}.
HELIX 271 287 {ECO:0000244|PDB:5J97}.
HELIX 298 311 {ECO:0000244|PDB:5J97}.
STRAND 999 1004 {ECO:0000244|PDB:4OUM}.
STRAND 1011 1016 {ECO:0000244|PDB:4OUM}.
STRAND 1020 1026 {ECO:0000244|PDB:4OUM}.
TURN 1032 1035 {ECO:0000244|PDB:4OUM}.
STRAND 1036 1038 {ECO:0000244|PDB:4OUM}.
STRAND 1041 1053 {ECO:0000244|PDB:4OUM}.
STRAND 1055 1058 {ECO:0000244|PDB:4OUM}.
STRAND 1060 1066 {ECO:0000244|PDB:4OUM}.
STRAND 1069 1076 {ECO:0000244|PDB:4OUM}.
STRAND 1079 1082 {ECO:0000244|PDB:4OUM}.
STRAND 1085 1094 {ECO:0000244|PDB:4OUM}.
STRAND 1099 1107 {ECO:0000244|PDB:4OUM}.
STRAND 1117 1126 {ECO:0000244|PDB:4OUM}.
SEQUENCE 1127 AA; 125925 MW; D74D1D284B69FA0F CRC64;
MEVQVSQASL GFELTSVEKS LREWSRLSRE VIAWLCPSSP NFILNFPPPP SASSVSMVQL
FSSPFGYQSP SGHSEEEREG NMKSAKPQVN HSQHGESQRA LSPLQSTLSS AASPSQAYET
YIENGLICLK HKIRNIEKKK LKLEDYKDRL KSGEHLNPDQ LEAVEKYEEV LHNLEFAKEL
QKTFSGLSLD LLKAQKKAQR REHMLKLEAE KKKLRTILQV QYVLQNLTQE HVQKDFKGGL
NGAVYLPSKE LDYLIKFSKL TCPERNESLS VEDQMEQSSL YFWDLLEGSE KAVVGTTYKH
LKDLLSKLLN SGYFESIPVP KNAKEKEVPL EEEMLIQSEK KTQLSKTESV KESESLMEFA
QPEIQPQEFL NRRYMTEVDY SNKQGEEQPW EADYARKPNL PKRWDMLTEP DGQEKKQESF
KSWEASGKHQ EVSKPAVSLE QRKQDTSKLR STLPEEQKKQ EISKSKPSPS QWKQDTPKSK
AGYVQEEQKK QETPKLWPVQ LQKEQDPKKQ TPKSWTPSMQ SEQNTTKSWT TPMCEEQDSK
QPETPKSWEN NVESQKHSLT SQSQISPKSW GVATASLIPN DQLLPRKLNT EPKDVPKPVH
QPVGSSSTLP KDPVLRKEKL QDLMTQIQGT CNFMQESVLD FDKPSSAIPT SQPPSATPGS
PVASKEQNLS SQSDFLQEPL QATSSPVTCS SNACLVTTDQ ASSGSETEFM TSETPEAAIP
PGKQPSSLAS PNPPMAKGSE QGFQSPPASS SSVTINTAPF QAMQTVFNVN APLPPRKEQE
IKESPYSPGY NQSFTTASTQ TPPQCQLPSI HVEQTVHSQE TAANYHPDGT IQVSNGSLAF
YPAQTNVFPR PTQPFVNSRG SVRGCTRGGR LITNSYRSPG GYKGFDTYRG LPSISNGNYS
QLQFQAREYS GAPYSQRDNF QQCYKRGGTS GGPRANSRAG WSDSSQVSSP ERDNETFNSG
DSGQGDSRSM TPVDVPVTNP AATILPVHVY PLPQQMRVAF SAARTSNLAP GTLDQPIVFD
LLLNNLGETF DLQLGRFNCP VNGTYVFIFH MLKLAVNVPL YVNLMKNEEV LVSAYANDGA
PDHETASNHA ILQLFQGDQI WLRLHRGAIY GSSWKYSTFS GYLLYQD


Related products :

Catalog number Product name Quantity
EIAAB05298 C1q domain-containing protein 1,C1QDC1,CAPRIN2,Caprin-2,Cytoplasmic activation_proliferation-associated protein 2,EEG1,Gastric cancer multidrug resistance-associated protein,Homo sapiens,Human,KIAA187
EIAAB05295 Bos taurus,Bovine,CAPRIN1,Caprin-1,Cytoplasmic activation- and proliferation-associated protein 1,RNA granule protein 105,RNG105
EIAAB05296 Caprin1,Caprin-1,Cytoplasmic activation- and proliferation-associated protein 1,GPI-anchored protein p137,Gpiap1,GPI-p137,p137GPI,Rat,Rattus norvegicus,RNA granule protein 105,Rng105
EIAAB05299 C1q domain-containing protein 1,C1qdc1,Caprin2,Caprin-2,Cytoplasmic activation_proliferation-associated protein 2,Kiaa1873,Mouse,Mus musculus,RNA granule protein 140,Rng140
EIAAB05294 CAPRIN1,Caprin-1,Cell cycle-associated protein 1,Cytoplasmic activation- and proliferation-associated protein 1,GPI-anchored membrane protein 1,GPI-anchored protein p137,GPIAP1,GPIP137,GPI-p137,Homo s
EIAAB05297 Caprin1,Caprin-1,Cytoplasmic activation- and proliferation-associated protein 1,G5E5,GPI-anchored membrane protein 1,GPI-anchored protein p137,Gpiap,Gpiap1,Gpip137,GPI-p137,M11s1,Membrane component ch
20-783-74648 MOUSE ANTI HUMAN BREAST CANCER RESISTANCE PROTEIN - Placenta-specific ATP-binding cassette transporter; Breast cancer resistance protein; Mitoxantrone resistance-associated protein; CD338 antigen; CDw 1 ml
EIAAB25426 Abcc2,ATP-binding cassette sub-family C member 2,Canalicular multidrug resistance protein,Canalicular multispecific organic anion transporter 1,Cmoat,Cmrp,Mrp2,Multidrug resistance-associated protein
EIAAB09918 ATPBD3,ATP-binding domain-containing protein 3,Cancer-associated gene protein,CTU1,Cytoplasmic tRNA 2-thiolation protein 1,Cytoplasmic tRNA adenylyltransferase 1,Homo sapiens,Human,NCS6
EIAAB25437 ABCC6,Anthracycline resistance-associated protein,ARA,ATP-binding cassette sub-family C member 6,Homo sapiens,Human,MOAT-E,MRP6,Multidrug resistance-associated protein 6,Multi-specific organic anion t
EIAAB25874 Influenza resistance protein,Interferon-induced GTP-binding protein Mx1,Mouse,Mus musculus,Mx1,Myxoma resistance protein 1,Myxovirus resistance protein 1
U0115r CLIA CD62 antigen-like family member P,GMP-140,Granule membrane protein 140,LECAM3,Leukocyte-endothelial cell adhesion molecule 3,PADGEM,Platelet activation dependent granule-external membrane protein 96T
EIAAB25438 Abcc6,ATP-binding cassette sub-family C member 6,Mlp1,MLP-1,Mrp6,MRP-like protein 1,Multidrug resistance-associated protein 6,Rat,Rattus norvegicus
EIAAB33291 E3 ubiquitin-protein ligase PDZRN3,Kiaa1095,Mouse,Mus musculus,PDZ domain-containing RING finger protein 3,Pdzrn3,Protein SEMACAP3,Semaphorin cytoplasmic domain-associated protein 3,Semcap3
EIAAB33289 E3 ubiquitin-protein ligase PDZRN3,PDZ domain-containing RING finger protein 3,Pdzrn3,Protein SEMACAP3,Rat,Rattus norvegicus,Semaphorin cytoplasmic domain-associated protein 3,Semcap3
EIAAB33290 E3 ubiquitin-protein ligase PDZRN3,Homo sapiens,Human,KIAA1095,Ligand of Numb protein X 3,LNX3,PDZ domain-containing RING finger protein 3,PDZRN3,Protein SEMACAP3,Semaphorin cytoplasmic domain-associa
EIAAB38179 DSHP,Duncan disease SH2-protein,Homo sapiens,Human,SAP,SH2 domain-containing protein 1A,SH2D1A,Signaling lymphocytic activation molecule-associated protein,SLAM-associated protein,T-cell signal transd
EIAAB37714 Homo sapiens,Human,MDA9,MDA-9,Melanoma differentiation-associated protein 9,Pro-TGF-alpha cytoplasmic domain-interacting protein 18,Scaffold protein Pbp1,SDCBP,SYCL,Syndecan-binding protein 1,Syntenin
E0960h ELISA ABCG2,ABCP,ATP-binding cassette sub-family G member 2,BCRP,BCRP1,Breast cancer resistance protein,CDw338,Homo sapiens,Human,Mitoxantrone resistance-associated protein,MXR,Placenta-specific ATP-b 96T
E0960h ELISA kit ABCG2,ABCP,ATP-binding cassette sub-family G member 2,BCRP,BCRP1,Breast cancer resistance protein,CDw338,Homo sapiens,Human,Mitoxantrone resistance-associated protein,MXR,Placenta-specific 96T
U0960h CLIA ABCG2,ABCP,ATP-binding cassette sub-family G member 2,BCRP,BCRP1,Breast cancer resistance protein,CDw338,Homo sapiens,Human,Mitoxantrone resistance-associated protein,MXR,Placenta-specific ATP-bi 96T
EIAAB25432 Abcc3,ATP-binding cassette sub-family C member 3,Canalicular multispecific organic anion transporter 2,Cmoat2,Mlp2,MLP-2,Mrp3,MRP-like protein 2,Multidrug resistance-associated protein 3,Rat,Rattus no
U1773h CLIA G-CSF-induced gene 1 protein,GIG1,GIG-1 protein,GMP-17,Granule membrane protein of 17 kDa,Homo sapiens,Human,Natural killer cell protein 7,NKG7,p15-TIA-1,Protein NKG7 96T
E1773h ELISA G-CSF-induced gene 1 protein,GIG1,GIG-1 protein,GMP-17,Granule membrane protein of 17 kDa,Homo sapiens,Human,Natural killer cell protein 7,NKG7,p15-TIA-1,Protein NKG7 96T
E1773h ELISA kit G-CSF-induced gene 1 protein,GIG1,GIG-1 protein,GMP-17,Granule membrane protein of 17 kDa,Homo sapiens,Human,Natural killer cell protein 7,NKG7,p15-TIA-1,Protein NKG7 96T

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP1689: Porphyrin and chlorophyll metabolism
WP210: Cytoplasmic Ribosomal Proteins
WP2199: Seed Development
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP1613: 1,4-Dichlorobenzene degradation
WP1616: ABC transporters
WP1624: Bacterial secretion system
WP1625: Base excision repair
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
WP1654: gamma-Hexachlorocyclohexane degradation
WP1657: Glycerolipid metabolism
WP1659: Glycine, serine and threonine metabolism
WP1661: Glyoxylate and dicarboxylate metabolism
WP1663: Homologous recombination
WP1665: Limonene and pinene degradation
WP1672: Mismatch repair
WP1673: Naphthalene and anthracene degradation

Related Genes :
[CD93 C1QR1 MXRA4] Complement component C1q receptor (C1q/MBL/SPA receptor) (C1qR) (C1qR(p)) (C1qRp) (CDw93) (Complement component 1 q subcomponent receptor 1) (Matrix-remodeling-associated protein 4) (CD antigen CD93)
[Adipoq Acdc Acrp30 Apm1] Adiponectin (30 kDa adipocyte complement-related protein) (Adipocyte complement-related 30 kDa protein) (ACRP30) (Adipocyte, C1q and collagen domain-containing protein) (Adipocyte-specific protein AdipoQ)
[ADIPOQ ACDC ACRP30 APM1 GBP28] Adiponectin (30 kDa adipocyte complement-related protein) (Adipocyte complement-related 30 kDa protein) (ACRP30) (Adipocyte, C1q and collagen domain-containing protein) (Adipose most abundant gene transcript 1 protein) (apM-1) (Gelatin-binding protein)
[Caprin1 Gpiap Gpiap1 Gpip137 M11s1 Rng105 G5E5] Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105)
[C1QTNF4 CTRP4] Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4)
[ADIPOQ ACRP30 APM1] Adiponectin (30 kDa adipocyte complement-related protein) (Adipocyte complement-related 30 kDa protein) (ACRP30) (Adipocyte, C1q and collagen domain-containing protein) (Adipose most abundant gene transcript 1 protein) (apM-1)
[Cd93 Aa4 C1qr1 C1qrp Ly68] Complement component C1q receptor (C1q/MBL/SPA receptor) (C1qR(p)) (C1qRp) (Cell surface antigen AA4) (Complement component 1 q subcomponent receptor 1) (Lymphocyte antigen 68) (Ly-68) (CD antigen CD93)
[C1QB] Complement C1q subcomponent subunit B
[C1QC C1QG] Complement C1q subcomponent subunit C
[C1QA] Complement C1q subcomponent subunit A
[C1ql4 C1qtnf11 Ctrp11] Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)
[C1QTNF3 CTRP3 UNQ753/PRO1484] Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)
[C1qtnf2 Crtp2] Complement C1q tumor necrosis factor-related protein 2 (mCTRP2)
[C1qtnf4 Ctrp4] Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4)
[C1qb] Complement C1q subcomponent subunit B
[C1QBP GC1QBP HABP1 SF2P32] Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33) (SF2AP32)
[Cd93 C1qr1 C1qrp] Complement component C1q receptor (C1q/MBL/SPA receptor) (C1qR(p)) (C1qRp) (Cell surface antigen AA4) (Complement component 1 q subcomponent receptor 1) (CD antigen CD93)
[RACK1 GNB2L1 HLC7 PIG21] Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]
[C1qb] Complement C1q subcomponent subunit B
[] Genome polyprotein [Cleaved into: Capsid protein C (Capsid protein) (Core protein); Protein prM (Precursor membrane protein); Peptide pr (Peptide precursor); Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[C1qa] Complement C1q subcomponent subunit A
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[EIF2AK2 PKR PRKR] Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase)
[C1qa] Complement C1q subcomponent subunit A
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[IFIH1 MDA5 RH116] Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116)
[] Genome polyprotein [Cleaved into: Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]

Bibliography :
?>